ライフサイエンスコーパス: patient management

1 o establish a conclusive diagnosis and guide patient management.

2 D, which might be target for intervention in patient management.

3 a, and gastroparesis, posing a challenge for patient management.

4 atory diagnosis is essential for appropriate patient management.

5 o results of approximately 45 min may impact patient management.

6 rlying etiology informs optimized individual patient management.

7 of anal cancer and has a relevant impact on patient management.

8 f systemic therapies for personalised cancer patient management.

9 d bone recurrences, thus having an impact on patient management.

10 they influence the practical approach toward patient management.

11 T iPET remains too low to justify changes in patient management.

12 s on clinical concepts guiding diagnosis and patient management.

13 erential diagnosis is critical to the proper patient management.

14 in those with HIV is recommended for optimal patient management.

15 arch questions and shape our approach toward patient management.

16 for when this technique can be beneficial in patient management.

17 osis and supported the medical staff in case patient management.

18 treatments is important for optimisation of patient management.

19 malignant transformation might influence the patient management.

20 identify aggressive forms are essential for patient management.

21 mproving diagnostic accuracy and influencing patient management.

22 ht the importance of risk stratification for patient management.

23 networks will maximize resources and improve patient management.

24 care, is essential for disease diagnosis and patient management.

25 e more informative for clinicians in guiding patient management.

26 The findings may be useful in patient management.

27 acilities could inform infection control and patient management.

28 , which may inform future stratification and patient management.

29 the exact role of mucosal biopsies for fVCA patient management.

30 , based on these data, suggest approaches to patient management.

31 f AF may guide an individualized approach to patient management.

32 stress potentially useful for diagnosis and patient management.

33 g the requirement for culture and benefiting patient management.

34 ave been added to some guidelines to improve patient management.

35 sion making regarding antibiotic therapy and patient management.

36 t clinical need by allowing for risk-adapted patient management.

37 tand the relationship of these findings with patient management.

38 ging studies are mandatory for pre-operative patient management.

39 disease manifestations can critically inform patient management.

40 rapy monitoring of PVGI and has an impact on patient management.

41 n risk stratification and help guide initial patient management.

42 ort and not supplant decisions in individual patient management.

43 (18)F-FDG PET/CT and had a further impact on patient management.

44 T scans to clinical assessment and impact on patient management.

45 confidential feedback and alternate views on patient management.

46 serve as predictive biomarkers to help guide patient management.

47 rspective with implications for etiology and patient management.

48 assist in the design of future trials and in patient management.

49 s one of the most important steps in optimal patient management.

50 methods for parasite staging in vivo, aiding patient management.

51 tic accuracy and new therapeutic targets for patient management.

52 entation in clinical trials and, ultimately, patient management.

53 ry arteries have significant stenoses and on patient management.

54 ortant for infection control, as well as for patient management.

55 proposed and will hopefully lead to improved patient management.

56 diologic imaging is located at the centre of patient management.

57 end points in clinical trials and to inform patient management.

58 hat might influence tailored improvements in patient management.

59 ease is a major challenge in prostate cancer patient management.

60 us reaction and treatment option to optimize patient management.

61 y in cases of morphological TCMR to optimize patient management.

62 be considered the main goal in acute stroke patient management.

63 growth factor receptor 2), which are used in patient management.

64 ntribute to more personalized and predictive patient management.

65 enotype correlations aid risk assessment and patient management.

66 ination of therapy efficacy is essential for patient management.

67 ce immunosuppressive strategies and optimize patient management.

68 notyping instead of rs12979860 would improve patient management.

69 argeted antibiotic prescription and improved patient management.

70 aning failure and lead to subsequent correct patient management.

71 so far, and have important implications for patient management.

72 rational diagnostic procedures and adequate patient management.

73 utility offers potential prognostic value in patient management.

74 ievable with phenotype alone and may improve patient management.

75 s and therapeutic targets that could improve patient management.

76 , and this procedure appears helpful for the patient management.

77 survival predictions become key elements in patient management.

78 ists who use such information to guide their patient management.

79 (18)F-FET PET as a highly relevant tool for patient management.

80 ay provide prognostic information useful for patient management.

81 ut tumor progression, because this may alter patient management.

82 d by A. tanneri and lead to more appropriate patient management.

83 erapeutic efficacy or toxicity could improve patient management.

84 s the resulting implications with respect to patient management.

85 ader will be able to apply these findings to patient management.

86 provide reassurance to families, and impact patient management.

87 I are used to add more practical findings in patient management.

88 s for inclusion into routine diagnostics and patient management.

89 se-by-case basis may be more significant for patient management.

90 ation of MIC data, with a possible impact on patient management.

91 cific allergic sensitization is required for patient management.

92 would be beneficial to inform treatment and patient management.

93 on of antifungal susceptibility profiles and patient management.

94 on of biopsy specimens, and thereby, improve patient management.

95 affects bone metastasis detection rates and patient management.

96 uropean, Web-based database, reports current patient management.

97 nical considerations, feasibility, risk, and patient management.

98 ations for clinical trial implementation and patient management.

99 r diagnosis of HIES is important for optimal patient management.

100 he value of (18)F-FDG PET/CT for guidance of patient management.

101 treatment can benefit both public health and patient management.

102 gated for their ability to aid in individual patient management.

103 ossible to give concrete recommendations for patient management.

104 atients, but without significantly affecting patient management.

105 e evolution of the disease could help inform patient management.

106 genetic risk and should be a strong focus in patient management.

107 y tests to assess iron status during routine patient management.

108 comes with the goal of optimizing individual patient management.

109 openia (HIT) is critical for guiding initial patient management.

110 disease prognosis and develop individualized patient management.

111 ngement injuries of the knee and helps guide patient management.

112 an emphasis on a Heart-Lung team approach in patient management.

113 c imaging, leading to changes in staging and patient management.

114 therapy monitoring is of great importance in patient management.

115 minant, or mixed, which serve as a guide for patient management.

116 implementing genomic information into future patient management.

117 diagnostic outcome and cost-effectiveness of patient management.

118 ar medicine expertise with therapy including patient management.

119 nomic features for the future improvement of patient management.

120 enables exploration of its utility to guide patient management.

121 patients to additional risk, and complicate patient management.

122 t cancer-related pain, creating a dilemma in patient management.

123 and estimated how this would affect standard patient management.

124 ion about disease activity, which can inform patient management.

125 iodontal specialist relationship and benefit patient management.

126 computed tomography (PET/CT) for guidance of patient management.

127 well as models, with potential to impact on patient management.

128 educe unnecessary antibiotic use and improve patient management.

129 ic phenotypes and might, ultimately, improve patient management.

130 ological and clinical implications in cancer patient management.

131 ifferential diagnosis is crucial for correct patient management.

132 ysicians calculated the HEART score to guide patient management.

133 clinical features, with clear relevance for patient management.

134 ram to describe diastolic function and guide patient management.

135 and now multidrug resistance greatly hampers patient management.

136 ogy, might suggest new strategies to improve patients management.

137 rs, yield was 44%); impact on subsequent NET patient management (4 papers, change in management in 51

138 dult inpatients with suspected CDI, assuming patient management according to laboratory results.

139 nding of stress hyperlactataemia to approach patient management according to logical principles.

140 formed to assess the concordance of intended patient management after NaF PET and inferred management

141 o a shorter LOS in this study, it simplified patient management after OLR.

142 international collaborative study to improve patients' management, aiming to individualize risk facto

143 While patient management aims to reduce pain and improve daily

144 Patient management always followed the decision made wit

145 ely still will be important to individualize patient management and approaches for this are discussed

146 hat are highly likely to form a component of patient management and care in the next decade.

147 (EBOV) detection is crucial for appropriate patient management and care.

148 e content of this report not only influences patient management and clinical outcomes but also serves

149 dated, could be a useful tool for individual patient management and clinical research studies.

150 ry open-angle glaucoma with an algorithm for patient management and detailed recommendations for eval

151 tory may be a simple, essential component of patient management and disease diagnosis.

152 omes; however, the impact of such testing on patient management and downstream testing has emerged as

153 care tests such as SAMBA should enable rapid patient management and effective implementation of infec

154 eding to surgery could substantially improve patient management and efficiency of the health system.

155 ous radionuclides has led to a revolution in patient management and established a foundation for expa

156 ssive disease has important implications for patient management and familial screening.

157 precision medicine at diagnosis can improve patient management and family counseling.

158 sease activity are urgently needed to inform patient management and for use as biomarkers of therapeu

159 children that should facilitate appropriate patient management and halt the practice of serial testi

160 tain cases a second) to identify issues with patient management and hospital processes.

161 a prognostic marker that could be useful for patient management and identifying individuals at risk o

162 the detection of unstable plaque can change patient management and improve outcomes.

163 be a useful prognostic marker for preventive patient management and improved healthcare resource mana

164 types might assist in providing personalised patient management and in selection for trials.

165 llow more effective triage in settings where patient management and infection control decisions need

166 diagnosis of influenza (Flu) is critical for patient management and infection control.

167 de clinically important information to guide patient management and monitor the response to antiangio

168 udy enrollment, important aspects related to patient management and monitoring, and standardized repo

169 onses to these conditions further complicate patient management and outcome prediction.

170 o efficiently address new questions, improve patient management and outcomes, and facilitate care coo

171 fficiently address new questions and improve patient management and outcomes.

172 risk factors of IRI-associated EAD may guide patient management and possible timely graft replacement

173 Lyme disease, has important implications for patient management and preventing further extracutaneous

174 ors in ulcerative colitis (UC) could improve patient management and reduce complications.

175 ediatric Crohn's disease (CD) should improve patient management and reduce complications.

176 However, its impact on patient management and safety when routinely applied is

177 sorafenib for any reason may help to improve patient management and second-line trial design.

178 PET/CT frequently affects patient management and strongly predicts OS in NSCLC, su

179 nt and assessed the impact of discordance on patient management and survival.

180 tigations at relapse may potentially improve patient management and survival.

181 hese roles offer a mix of guidance regarding patient management and the appropriate use and stewardsh

182 Beyond the expected improvement in patient management and the potential impact on patient o

183 lying hepatic dysfunction, which complicates patient management and the search for safe and effective

184 e profiles are needed to optimize individual patient management and to develop treatment guidelines.

185 e profiles are needed to optimize individual patient management and to develop treatment guidelines.

186 sionals with unique opportunities to improve patient management and to encourage lifestyle-based stra

187 d diagnosis of infection, guiding individual patient management and treatment strategies, and informi

188 nit volume have potent influences on initial patient management and treatment.

189 propriate medical reason had a low impact on patients' management and should be avoided.

190 itically important for accurate direction of patient management, and evokes broader genetic counselli

191 argeted and immune therapies, review current patient management, and highlight future directions.

192 aration, and phase 2 focuses on containment, patient management, and quarantine.

193 es, health system efficiency by streamlining patient management, and the quality of health and social

194 on method can potentially improve diagnosis, patient management, and treatment response assessment an

195 CFH and the benefits of proactive high-risk patient management are clearly needed.

196 will be needed because the implications for patient management are uncertain.

197 rtery disease, but its effects on subsequent patient management are unclear.

198 f diagnosis in bronchoscopy units, regarding patient management, are likely to have clinical impact i

199 ffort has been made to improve and harmonize patient management as documented in several guidelines a

200 ajor implications for genetic counseling and patient management as new therapeutic options are being

201 These biomarkers have implications for patient management at recurrence.

202 Impact on patient management based on (18)F-DCFPyL PET/CT was reco

203 ew of early-relapsing FL and our approach to patient management based on recent available data.

204 act dPCR could have on clinical research and patient management by earlier (trace) detection of rare

205 and delineation, thus potentially affecting patient management by improving diagnosis, prognosticati

206 MCS centers have improved patient management by introducing standardized driveline

207 Such agents have the potential to improve patient management by selecting individuals for HER2-tar

208 (18)F-FLT PET may thus aid in personalized patient management by steering treatment modifications d

209 nts compared remote monitoring with standard patient management consisting of scheduled visits and pa

210 ity field surveillance to improve diagnosis, patient management, control, and prevention of invasive

211 Many apps involve diagnosis and patient management, creating a need for regulations and

212 alues at the 50 copies/mL cutoff drive major patient management decisions and clinical study outcomes

213 ortality after esophagectomy reflects cancer patient management decisions and may provide actionable

214 measure myocardial salvage, either to inform patient management decisions or to evaluate novel therap

215 at a later time and were not used to modify patient management decisions.

216 ative prognostic biomarker that could inform patient management decisions.

217 ion and associated serological responses for patient-management decisions.

218 this kind of treatment, expected outcome and patient management during MR-HIFU procedure.

219 y based on statistical models are needed for patient management during the early years following the

220 which (1)H MR spectroscopy may contribute to patient management extends to neurodegenerative diseases

221 uld potentially be used to positively affect patient management for Staphylococcus-mediated bacteremi

222 n testing is a novel noninvasive approach to patient management for the diagnosis and prediction of P

223 s the POC EID test request form was used for patient management for the duration of the project.

224 east cancer by a pathologist is critical for patient management for tumor staging and assessing treat

225 , the technique of liver transplantation and patient management has evolved considerably.

226 routine FFR at the time of diagnostic CA on patient management has not been determined.

227 ubsets have been increasingly characterized, patient management has remained disappointingly uniform.

228 anatomy- and physiology-based approaches to patient management have advantages and limitations.

229 t data and improvements in multidisciplinary patient management have established a standard of care a

230 iology of pancreatic cancer, and advances in patients' management have also taken place.

231 DG-PET has the potential to improve lymphoma patient management; however, its usefulness will likely

232 obstruction have different implications for patient management; however, their relative contribution

233 There was a 63% (24/38 patients) management impact, with 54% (13/24 patients) b

234 to misinterpretation, which potentially has patient management implications.

235 d benchmarks for clinical decision-making in patient management, improved prognostication, and eviden

236 (18)F-FDG PET/CT changed patient management in 14 cases (16%), with relevant modi

237 The results of staging PET had an impact on patient management in 37% of patients (P < 0.003).

238 PET/CT examination results influenced patient management in 48% of cases (34/71).

239 idence in about 60% of cases, to a change in patient management in about 60% of cases, and specifical

240 (ASA) and surgical septal myectomy (SM) with patient management in accordance with these consensus gu

241 Contact resulted in attending-led changes in patient management in one-third of cases.

242 nipulate the intestinal microbiota and guide patient management in pancreatic diseases.

243 T scans to clinical assessment and impact on patient management in patients with colorectal cancer.

244 se models have been shown to be effective in patient management in programs in resource-limited setti

245 mmonly used in the clinic, may be useful for patient management in the event of future nCoV infection

246 Sequencing results altered patient management in the majority of suspected cases.

247 or "high-complexity" treatment decisions in patient management in the presence of advanced healthcar

248 ntributing to better genetic counselling and patient management in the respective families from this

249 lar tests assist at various stages of cancer patient management, including providing diagnosis, predi

250 developed the Tools for Economic Analysis of Patient Management Interventions in Heart Failure (TEAM-

251 Patient management is difficult due to the absence of pa

252 mplementation of precision medicine, whereby patient management is tailored to the individual accordi

253 ed value of mucosal rejection assessment for patient management is unknown.

254 Healthcare information, and to some extent patient management, is progressing toward a wireless dig

255 s in transplantation represents a new era in patient management, it is important for clinicians to be

256 ection in case of ALF, though improvement of patient management may have contributed.

257 We conclude that routine TBI patient management may limit the clinical utility of blo

258 Consequently, to improve patient management modalities, a better understanding of

259 of lung-protective strategies may complicate patient management, motivating a search for better lung-

260 uated the safety, sensitivity, and impact on patient management of (18)F-DCFPyL in the setting of bio

261 is recommended for screening/diagnosing and patient management of diabetes.

262 ill give providers the options for improving patient management on the basis of pharmacogenetic data.

263 ng for coccidioidomycosis might be useful in patient management or as a research tool.

264 of screening studies are unlikely to change patient management or the intensity of risk factor reduc

265 We analysed patients' management over three epochs (before 1995, 199

266 ET/CT imaging has become an integral part of patient management, particularly in oncology.

267 fying these patients at biopsy might improve patient management, particularly with regard to active s

268 in vivo may have important implications for patient management, patient selection for trials, and to

269 ases, and increased surgeon comfort with the patient management plan in 95% (94 of 99) of cases.

270 or clinicians in choosing the most effective patient management plan that maximizes survivorship and

271 profiling of patients and the development of patient management protocols.

272 c coverage for symptomatic women and improve patient management, regardless of the type of clinic in

273 tions have not been evaluated in vivo; thus, patient management relies exclusively on supportive care

274 Patient management relies on diagnostic information to i

275 ively charted, but the improvement of cancer patient management somewhat lags behind these basic brea

276 patient selection, operative technique, and patient management strategies have been refined, leading

277 rformed before these data can be included in patient management strategies.

278 sk and improve survival by informing post-LT patient management strategies.

279 information gained from routine FFR affects patient management strategy and clinical outcome.

280 ents, introducing an additional challenge in patient management, such as ensuring an optimal adherenc

281 tional Minimum Dataset, the Geelong Hospital patient management system in Australia, and purpose-buil

282 To optimize patient management, there is a great need to accurately

283 Patient management therefore often requires multiple ant

284 In addition to optimizing individual patient management, these baseline resistance data enabl

285 rs in which MR spectroscopy has an impact on patient management, together with a critical considerati

286 e understanding of disease relationships and patient management towards improved clinical outcomes.

287 Patient management vignettes varied by patient race or s

288 l information that could significantly alter patient management, warranting further investigation for

289 Additionally, the influence of SPECT/CT on patient management was evaluated.

290 the impact of each of the 12 indications on patients' management was evaluated.

291 In this randomized pilot study of LVAD patient management we demonstrated the feasibility of st

292 cost of the devices, ECG interpretation, and patient management were captured and used to generate th

293 stage after (18)F-FDG PET/CT, and change in patient management were determined.

294 g inpatient care; significant alterations in patient management were noted in one-third of cases in w

295 severity, computed tomography findings, and patient management were registered.

296 e difficult to make informed decisions about patient management when the precise diagnosis remains un

297 rtened and may be beneficial to patients and patient management while reducing the radiation exposure

298 osis and XDR tuberculosis greatly complicate patient management within resource-poor national tubercu

299 ic work-up of MCDs with the aim of improving patient management worldwide.

300 diate outcomes, such as a positive change in patient management, would be more efficient and appropri